Article
Development and Biological Evaluation of a Novel Aurora A Kinase Inhibitor
6 Feb 2009
Abstract excerpt
STOP DIVIDING: In the quest for antitumorigenic compounds, aurora A kinase has recently emerged as a potential drug target. In this paper three novel aurora inhibitors (shown in the illustration) have been tested for their biological activity in cultured cells. One of them (TC-28) appears to be a promising specific aurora A inhibitor in vivo. The aurora kinase family groups several serine/threonine kinases with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
